IEX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/11/2026 15:59
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization281.58 mln
Float10.20 mln
Earnings Date10/29/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.67
Likely reliable
1-Year Forecast
21.00
Fairly priced
Relative Strength
74
/ 100
Outperforming
Debt / Equity
0.18
Very low leverage
Pre-Tax Margin
-2%
Barely loss-making
Business Description
Anika Therapeutics is a company focused on protecting joint health and reducing the need for invasive procedures, serving patients across the United States, Europe, and other global markets. Founded in 1983 and based in Bedford, Massachusetts, the company develops a broad range of products aimed at treating joint pain, repairing damaged tissue, and supporting bone health ? with a particular emphasis on osteoarthritis. Its offerings include injectable pain relief treatments, cartilage regeneration solutions, and bone repair therapies, alongside products for veterinary, surgical, and eye care applications.
